Issue Date: October 16, 2017 | Web Date: October 12, 2017
Bryostatin advances: A shorter synthesis and an HIV takedown
The marine natural product bryostatin 1 has shown promise as a treatment for cancer, Alzheimer’s disease, and HIV. But neither the compound nor its analogs have become approved drugs. One of the problems that has dogged bryostatin 1 is its scarce supply. Now, chemists at Stanford University led by Paul A. Wender have developed a shortened synthesis of bryostatin 1 . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society